Nordic Biomarker Overview

  • Founded
  • 2007
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Nordic Biomarker General Information


Manufacturer of latex reagents designed for coagulation clinical chemistry analyzers. The company's reagents are focused on the development and manufacturing of latex immunoassays, for example reagents for testing D-dimer, FDP and Free Protein S, enabling OEM clients to sell the products to hospital laboratories with their own brand names.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Primary Office
  • Umestan Företagspark 135
  • 903 47 Umea
  • Sweden
+46 090-71 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nordic Biomarker Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view Nordic Biomarker’s complete valuation and funding history, request access »

Nordic Biomarker Executive Team (4)

Name Title Board Seat Contact Info
Rikard Rodén Chief Executive Officer
Anna Gimlander Chief Financial Officer
Göran Aronsson Ph.D Co-Founder & Director, Business Development
Gunnar Pohl Ph.D Co-Founder & Senior Advisor
To view Nordic Biomarker’s complete executive team members history, request access »

Nordic Biomarker Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Umeå Biotech Incubator Accelerator/Incubator Minority 000 0000 000000 0
To view Nordic Biomarker’s complete investors history, request access »